. Author manuscript; available in PMC: 2016 Jan 31.

Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2014 Jul 15;15(2):110–114. doi: 10.1016/j.clml.2014.07.001

Table 3.

Multivariate Analysis for Time to t-MN

	HR	95% CI	p-value

Age at diagnosis	1.09	(1.04, 1.15)	0.001
Initial Rx for Multiple Myeloma
Conventional agents
Novel agents	0.31	(0.08, 1.15)	0.081
Both	1.08	(0.40, 2.94)	0.883
M spike
IgG (Kappa or Lambda)
IgA (Kappa or Lambda)	3.96	(1.16, 13.54)	0.028
Light Chain	4.71	(1.17, 18.92)	0.029